OCX Oncocyte Corp

OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer.

As of 10/03/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  12/30/2015
Outstanding shares:  118,608,821
Average volume:  250,505
Market cap:   $87,770,528
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BYQRGG0
Valuation   (See tab for details)
PE ratio:   -1.23
PB ratio:   1.18
PS ratio:   10.93
Return on equity:   -123.70%
Net income %:   -877.90%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy